3,4-Methylenedioxy-N-isopropylamphetamine

3,4-Methylenedioxy-N-isopropylamphetamine (MDIP) is a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes. It acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA) with empathogenic effects.

Chemistry[edit | edit source]

MDIP is a substituted amphetamine featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain. It is structurally related to MDMA, but the methyl group attached to the nitrogen atom is replaced by an isopropyl group.

Pharmacology[edit | edit source]

MDIP acts as a potent and balanced serotonin, norepinephrine, and dopamine releasing agent. This is believed to result in its empathogenic effects. The exact pharmacological mechanisms of MDIP are still under research.

Effects[edit | edit source]

The effects of MDIP can vary greatly, depending on the dose and individual's physiology. Common effects include feelings of euphoria, increased sociability, and emotional openness. However, potential adverse effects can include anxiety, paranoia, and neurotoxicity.

Legal Status[edit | edit source]

The legal status of MDIP varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and addiction.